Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Humboldt Seed Organization is an active cannabis genetics and seed company originating from Northern California. The company markets premium cannabis seeds and breeding expertise, with a portfolio spanning feminized, autoflowering, fast-flowering, and CBD-rich varieties for home growers, small farmers, and commercial cultivators. Its positioning emphasizes stable genetics, phenotype selection, regenerative agriculture, and science-informed breeding. HSO also states that it has pursued pharmaceutical research and development partnerships and university collaborations related to cannabis genetics, but its core business is commercial seed sales rather than human therapeutics. It is best classified as a cannabis breeder/seed business rather than a life science, biotech, pharma, or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Humboldt Seed Organization.